Adrenalectomy stimulates the formation of initial atherosclerotic lesions: Reversal by adrenal transplantation

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 76-83

  van der Sluis, Ronald J ^a   van Puijvelde, Gijs H ^a   Van Berkel, Theo J C ^a   Hoekstra, Menno ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adrenal; Adrenalectomy; Atherosclerosis; Cholesterol; LDL receptor knockout mice; Lymphocyte; Steroidogenesis

Indexed keywords

CHOLESTEROL; CORTICOSTERONE; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADRENAL GLAND TRANSPLANTATION; ADRENAL MEDULLA; ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; STEROID RELEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENAL GLANDS; ADRENALECTOMY; ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; CHOLESTEROL; CORTICOSTERONE; CYTOKINES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 84857030413     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.022     Document Type: Article

References (36)

1. Bergthorsdottir R., Leonsson-Zachrisson M., Odén A., Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006, 91:4849-4853.
2. Mancini T., Kola B., Mantero F., Boscaro M., Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004, 61:768-777.
3. Whitworth J.A., Williamson P.M., Mangos G., Kelly J.J. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 2005, 1:291-299.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
5. Imai E., Miner J.N., Mitchell J.A., Yamamoto K.R., Granner D.K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993, 268:5353-5356.
6. Cleasby M.E., Kelly P.A., Walker B.R., Seckl J.R. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 2003, 144:999-1007.
7. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
8. Wang D., Müller N., McPherson K.G., Reichardt H.M. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J Immunol 2006, 176:1695-1702.
9. Herold M.J., McPherson K.G., Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006, 63:60-72.
10. van Wanrooij E.J., van Puijvelde G.H., de Vos P., Yagita H., van Berkel T.J., Kuiper J. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2007, 27:204-210.
11. van Wanrooij E.J., de Jager S.C., van Es T., et al. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:251-257.
12. Von Der Thüsen J.H., Kuiper J., Fekkes M.L., De Vos P., Van Berkel T.J., Biessen E.A. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 2001, 15:2730-2732.
13. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92:883-893.
14. Nakanishi T., Kuroiwa A., Yamada S., et al. FISH analysis of 142 EGFP transgene integration sites into the mouse genome. Genomics 2002, 80:564-574.
15. Karpac J., Ostwald D., Bui S., Hunnewell P., Shankar M., Hochgeschwender U. Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice. Endocrinology 2005, 146:2555-2562.
16. Hoekstra M., Kruijt J.K., Van Eck M., Van Berkel T.J. Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J Biol Chem 2003, 278:25448-25453.
17. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
18. VanderLaan P.A., Reardon C.A., Thisted R.A., Getz G.S. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res 2009, 50:376-385.
19. Brenner R.M., Patt D.I., Wyman L.C. Cellular changes during adrenocortical regeneration in the rat. Anat Rec 1953, 117:759-771.
20. Hoekstra M., Ye D., Hildebrand R.B., et al. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J Lipid Res 2009, 50:1039-1046.
21. Hoekstra M., Meurs I., Koenders M., et al. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting. J Lipid Res 2008, 49:738-745.
22. Feldman D., Mondon C.E., Horner J.A., Weiser J.N. Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Am J Physiol 1979, 237:E493-E499.
23. Dolinsky V.W., Douglas D.N., Lehner R., Vance D.E. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. Biochem J 2004, 378:967-974.
24. Berthiaume M., Laplante M., Festuccia W.T., et al. 11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. Am J Physiol Endocrinol Metab 2007, 293:E1045-E1052.
25. Nuotio-Antar A.M., Hachey D.L., Hasty A.H. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 2007, 293:E1517-E1528.
26. Getz G.S., Reardon C.A. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:242-249.
27. Nasir K., Guallar E., Navas-Acien A., Criqui M.H., Lima J.A. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 2005, 25:1966-1971.
28. Wheeler J.G., Mussolino M.E., Gillum R.F., Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004, 25:1287-1292.
29. Madjid M., Awan I., Willerson J.T., Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004, 44:1945-1956.
30. Di Angelantonio E., Sarwar N., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000. Emerging Risk Factors Collaboration.
31. Cai L., Ji A., de Beer F.C., Tannock L.R., van der Westhuyzen D.R. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008, 118:364-375.
32. Roggero E., Pérez A.R., Tamae-Kakazu M., et al. Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol 2006, 190:495-503.
33. Koniaris L.G., Wand G., Wright T.M. TNF mediates a murine model of Addison's crisis. Shock 2001, 15:29-34.
34. Castonguay T.W., Beaulieu S., Eskay R.L., et al. The effects of adrenalectomy and aldosterone replacement in transgenic mice expressing antisense RNA to the type 2 glucocorticoid receptor. Physiol Behav 2002, 77:417-423.
35. Sharabi Y., Grossman E., Sherer Y., et al. The effect of renin-angiotensin axis inhibition on early atherogenesis in LDL-receptor-deficient mice. Pathobiology 2000, 68:270-274.
36. Shimizu H., Ohshima K., Bray G.A., Peterson M., Swerdloff R.S. Adrenalectomy and castration in the genetically obese (ob/ob) mouse. Obes Res 1993, 1:377-383.